GERD: An Old Problem with New Approaches
Download
Report
Transcript GERD: An Old Problem with New Approaches
GERD:
An Old Problem with New
Approaches
Jason Phillips, MD
Case
HPI: 44 y/o M with heartburn
• Heartburn symptoms off/on for many years
but increasing in severity and frequency in last
6-12 months
• Symptoms are described as:
Sternal ‘burning’ with acid taste in mouth
Occurs most frequently at night most days of the
week
Last hours
Partially relieved with Mylanta
Case
Exacerbated by:
• Supine positions after meal
• Large meals
• Food triggers: pasta, greasy food,
coffee, alcohol
Denies weight loss, dysphagia,
melena, hematemesis
Case
PMH: Obesity
Meds: Mylanta
NKDA
SH: smokes 1ppd x 10+years, drinks
2-4 glasses of wine per night
FH: No h/o esophageal Ca
Case
PE: BP 140/86 P 96 Afeb
Wt 275 lbs (BMI 36)
Gen: obese, NAD
Exam essentially normal
Case
Pt was seen by his PCP and
diagnosed with GERD.
• Prescribed a PPI to take once a day.
• Advised pt to lose weight and quit
smoking
• Follow-up in 4-6 weeks
Case
At 5 weeks, he called his PCP and
complained he was still having daily
episodes of heartburn though ‘the
medicine helped a little’
• PCP’s 3 options:
Increase PPI to BID
Change PPI
Referral to GI
Case
PPI was increased to BID and the
patient continued to have reflux
symptoms
Therefore, the pt was referred to GI
for further evaluation
Case
GI visit: Additional history
• Pts symptoms sounded like typical
reflux-like symptoms
• Symptoms mostly occurred from 8-10
PM after his dinner at 7 PM
• Large evening meals most days
• Had not tried avoiding typical food
triggers
• Had not lost weight or stopped smoking
Case
GI visit: Additional history
• He was taking his PPI 30 minutes after
meals (during dessert) twice per day as
recommended
• His symptoms overall improved by
~50% but as mentioned, he continued
to have daily symptoms
Case
GI visit: Additional history
Reflux events also increased during
the day during stressful moments at
work
Case
Possible diagnoses
• Inadequately treated GERD vs
functional heartburn
• Malignancy
• Esophageal spasm
• Peptic ulcer disease
• Angina
Case
EGD while still taking medications:
• normal esophagus with no evidence of
esophagitis or Barrett’s esophagus
• Normal stomach and duodenum
Case
Does he have non-erosive acid reflux
that is inadequately treated with his
current PPI or is this functional
heartburn?
Case
To distinguish, I arranged for the
patient to have a 24 pH probe while
still taking his BID PPI
Bravo wireless 24 hour pH probe
Case
Diagnosed with acid reflux
Recommendations
• BID PPI – taken 30 minutes BEFORE
meals
• Additional nocturnal H2 blocker
• Behavioral modifications
Earlier dinner, smaller portions
Avoidance of trigger foods
Quit smoking
Lose weight
GERD Incidence
Complaints of heartburn
• 40% of Americans complain of monthly
heartburn
• 20% complain of weekly heartburn
• 7% complain of daily heartburn
Prevalence of GERD is increasing over the
30 years
Problem of GERD
Difficult to define
Physiologic vs pathologic acid reflux
• Physiologic postprandial, short lived,
asymptomatic, rarely during sleep
• Pathologic symptoms, often include
nocturnal episodes
Symptoms
Heartburn
Epigastric pain
Regurgitation
Dysphagia
Chest pain
Nausea
Odynophagia
Globus sensation
Supraesophageal symptoms
Symptoms
Patient’s descriptions can be difficult
to interpret: “Its not heartburn its…
• “…bile coming up into my throat.”
• “…intense pain in my stomach.”
• “…its not pain, its heaviness in my
chest.”
• “…pain in the back of my throat when I
awake.”
Pathophysiology
80% of reflux symptoms occur as a
result of transient LES relaxation
Other motility defects
• LES incompetence
• Gastroparesis
• Esophageal body dymotility
Anatomic defects: Hiatal hernia
Diagnosis
Symptoms empiric PPI
• Uncomplicated symptoms (no alarm
signs – weight loss, GI bleeding,
dysphagia)
• Age < 65 years
• No esophagotoxic medications (e.g,
bisphophonates)
• 6 weeks trial
Diagnosis: Empiric treatment
Sensitivity ~75%
Specificity ~80%
Using 50% improvement as the
therapeutic endpoint
• Schindlbeck et al…Arch Int Med 155:1808-12,
1995
• Fass et al…Arch Int Med 159:2161-8, 1999
Evaluation of GERD
In patients who have ‘red flags’ or
fail 6 weeks of a PPI EGD
EGD:
• signs of esophagitis
• Barrett’s esophagus
• Hiatal hernias
• Exclusion of cancer and other diagnoses
(PUD)
Evaluation of GERD
Evaluation of GERD
PillCam may offer a non-invasive
method to look for evidence of
esophagitis or Barrett’s esophagus
PillCam
Identified 97% (32/33) of the cases of
Barrett’s esophagus when confirmed by
traditional endoscopy
Agreed 99% (72/73) of the time in
excluding Barrett’s esophagus confirmed
by traditional EGD
Identified 89% (33/37) of the cases of
esophagitis
Agreed 99% (68/69) of the cases of ‘no
evidence of esophagitis’
Eliakim et al… Preliminary results. ACG 2004.
Evaluation
75% of community based EGD for
evaluation of GERD have NO
evidence of mucosal injury
50% of patients with endoscopy
negative reflux disease have
abnormal esophageal acid exposure
In these cases, other tests are
needed
Ambulatory pH monitor
Considered to be the most sensitive
test for diagnosing reflux
Traditional transnasal catheter
with probe situated 5 cm above LES
Bravo pH system wireless
technology
Treatment
PPI are standard medical therapy
• Daily PPI generally has a 80% healing
rate for moderate to severe esophagitis
and relief of symptoms in up to 90% of
patients
Overall, all PPI are equally effective
in treating symptoms. However,
there is some variability in response
from patient to patient
Treatment
Proper timing of PPI administration is
critical for efficacy
30 minutes before breakfast or other
large meal
In select patients, a second dose can
be added before the evening meal
Surgical Treatment
Indications
• Esophagitis
• Stricture
• Barrett’s metaplasia
• Medication failure
Purpose of surgery restoration
the LES
Surgical Treatment
Most studies indicate that the majority of
patients are symptom-free (70-95%)
Recent studies suggest that after 5 years,
up to 1/3 of patients required PPI to
control symptoms. At 10 years, up to 50%
require PPIs
Side-effects: gas-bloat symptoms,
diarrhea, dysphagia
Endoscopic Treatments
In development with ongoing studies
Most try to improve LES function in
some manner
Not quite ready for prime time in
community practice
Stretta procedure
Stretta procedure
Decrease in
symptom score
Decreased PPI
No effect on LESP
No effect on acid
exposure
Some serious
thermal injury
complications
Enteryx injection
Enteryx injection
Decreased in heartburn symptoms
Decreased 24 hour acid exposure
Decreased need for PPI
No improvement in severity of
esophagitis at EGD
Long term safety issues not known
Endoscopic suturing
Endoscopic suturing
Decreased heartburn symptoms
PPI eliminated in 74% of patients at
6 months
Decreased esophageal acid
exposure; however, only 30%
completely normalized
Long term follow-up needed
Questions?